200 related articles for article (PubMed ID: 32739889)
1. Application of the Extended Clearance Classification System (ECCS) in Drug Discovery and Development: Selection of Appropriate In Vitro Tools and Clearance Prediction.
Umehara K; Cantrill C; Wittwer MB; Di Lenarda E; Klammers F; Ekiciler A; Parrott N; Fowler S; Ullah M
Drug Metab Dispos; 2020 Oct; 48(10):849-860. PubMed ID: 32739889
[TBL] [Abstract][Full Text] [Related]
2. Drug Design and Success of Prospective Mouse In Vitro-In Vivo Extrapolation (IVIVE) for Predictions of Plasma Clearance (CL
Manevski N; Umehara K; Parrott N
Mol Pharm; 2023 Jul; 20(7):3438-3459. PubMed ID: 37235687
[TBL] [Abstract][Full Text] [Related]
3. In Vitro to In Vivo Extrapolation of Metabolic Clearance for UGT Substrates Using Short-Term Suspension and Long-Term Co-cultured Human Hepatocytes.
Docci L; Klammers F; Ekiciler A; Molitor B; Umehara K; Walter I; Krähenbühl S; Parrott N; Fowler S
AAPS J; 2020 Oct; 22(6):131. PubMed ID: 33051808
[TBL] [Abstract][Full Text] [Related]
4. Comparison of In Vitro to In Vivo Extrapolation Approaches for Predicting Transporter-Mediated Hepatic Uptake Clearance Using Suspended Rat Hepatocytes.
Li N; Badrinarayanan A; Li X; Roberts J; Hayashi M; Virk M; Gupta A
Drug Metab Dispos; 2020 Oct; 48(10):861-872. PubMed ID: 32759366
[TBL] [Abstract][Full Text] [Related]
5. Predicting Clearance Mechanism in Drug Discovery: Extended Clearance Classification System (ECCS).
Varma MV; Steyn SJ; Allerton C; El-Kattan AF
Pharm Res; 2015 Dec; 32(12):3785-802. PubMed ID: 26155985
[TBL] [Abstract][Full Text] [Related]
6. Albumin-Mediated Uptake Improves Human Clearance Prediction for Hepatic Uptake Transporter Substrates Aiding a Mechanistic In Vitro-In Vivo Extrapolation (IVIVE) Strategy in Discovery Research.
Li N; Badrinarayanan A; Ishida K; Li X; Roberts J; Wang S; Hayashi M; Gupta A
AAPS J; 2020 Nov; 23(1):1. PubMed ID: 33196949
[TBL] [Abstract][Full Text] [Related]
7. Improving Prediction of Metabolic Clearance Using Quantitative Extrapolation of Results Obtained From Human Hepatic Micropatterned Cocultures Model and by Considering the Impact of Albumin Binding.
Da-Silva F; Boulenc X; Vermet H; Compigne P; Gerbal-Chaloin S; Daujat-Chavanieu M; Klieber S; Poulin P
J Pharm Sci; 2018 Jul; 107(7):1957-1972. PubMed ID: 29524447
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the Predictability of Human Hepatic Clearance for Organic Anion Transporting Polypeptide Substrate Drugs Between Different In Vitro-In Vivo Extrapolation Approaches.
Izumi S; Nozaki Y; Komori T; Takenaka O; Maeda K; Kusuhara H; Sugiyama Y
J Pharm Sci; 2017 Sep; 106(9):2678-2687. PubMed ID: 28238896
[TBL] [Abstract][Full Text] [Related]
9. In Vitro-In Vivo Extrapolation and Scaling Factors for Clearance of Human and Preclinical Species with Liver Microsomes and Hepatocytes.
Tess D; Chang GC; Keefer C; Carlo A; Jones R; Di L
AAPS J; 2023 Apr; 25(3):40. PubMed ID: 37052732
[TBL] [Abstract][Full Text] [Related]
10. Organic Anion Transporter 2-Mediated Hepatic Uptake Contributes to the Clearance of High-Permeability-Low-Molecular-Weight Acid and Zwitterion Drugs: Evaluation Using 25 Drugs.
Kimoto E; Mathialagan S; Tylaska L; Niosi M; Lin J; Carlo AA; Tess DA; Varma MVS
J Pharmacol Exp Ther; 2018 Nov; 367(2):322-334. PubMed ID: 30135178
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the Disconnect between Hepatocyte and Microsome Intrinsic Clearance and In Vitro In Vivo Extrapolation Performance.
Williamson B; Harlfinger S; McGinnity DF
Drug Metab Dispos; 2020 Nov; 48(11):1137-1146. PubMed ID: 32847864
[TBL] [Abstract][Full Text] [Related]
12. In Vitro - in Vivo Extrapolation of Hepatic Clearance in Preclinical Species.
Tess DA; Ryu S; Di L
Pharm Res; 2022 Jul; 39(7):1615-1632. PubMed ID: 35257289
[TBL] [Abstract][Full Text] [Related]
13. Strategies to improve the prediction accuracy of hepatic intrinsic clearance of three antidiabetic drugs: Application of the extended clearance concept and consideration of the effect of albumin on CYP2C metabolism and OATP1B-mediated hepatic uptake.
Fujino R; Hashizume K; Aoyama S; Maeda K; Ito K; Toshimoto K; Lee W; Ninomiya SI; Sugiyama Y
Eur J Pharm Sci; 2018 Dec; 125():181-192. PubMed ID: 30287410
[TBL] [Abstract][Full Text] [Related]
14. Direct Comparison of Total Clearance Prediction: Computational Machine Learning Model versus Bottom-Up Approach Using In Vitro Assay.
Kosugi Y; Hosea N
Mol Pharm; 2020 Jul; 17(7):2299-2309. PubMed ID: 32478525
[TBL] [Abstract][Full Text] [Related]
15. Improving In Vitro-In Vivo Extrapolation of Clearance Using Rat Liver Microsomes for Highly Plasma Protein-Bound Molecules.
Trunzer M; Teigão J; Huth F; Poller B; Desrayaud S; Rodríguez-Pérez R; Faller B
Drug Metab Dispos; 2024 Apr; 52(5):345-354. PubMed ID: 38360916
[TBL] [Abstract][Full Text] [Related]
16. Meeting the challenge of predicting hepatic clearance of compounds slowly metabolized by cytochrome P450 using a novel hepatocyte model, HepatoPac.
Chan TS; Yu H; Moore A; Khetani SR; Tweedie D
Drug Metab Dispos; 2013 Dec; 41(12):2024-32. PubMed ID: 23959596
[TBL] [Abstract][Full Text] [Related]
17. Metabolic Profiling of Human Long-Term Liver Models and Hepatic Clearance Predictions from In Vitro Data Using Nonlinear Mixed-Effects Modeling.
Kratochwil NA; Meille C; Fowler S; Klammers F; Ekiciler A; Molitor B; Simon S; Walter I; McGinnis C; Walther J; Leonard B; Triyatni M; Javanbakht H; Funk C; Schuler F; Lavé T; Parrott NJ
AAPS J; 2017 Mar; 19(2):534-550. PubMed ID: 28050713
[TBL] [Abstract][Full Text] [Related]
18. Impact of Plasma Protein Binding in Drug Clearance Prediction: A Data Base Analysis of Published Studies and Implications for In Vitro-In Vivo Extrapolation.
Francis LJ; Houston JB; Hallifax D
Drug Metab Dispos; 2021 Mar; 49(3):188-201. PubMed ID: 33355201
[TBL] [Abstract][Full Text] [Related]
19. Projecting ADME Behavior and Drug-Drug Interactions in Early Discovery and Development: Application of the Extended Clearance Classification System.
El-Kattan AF; Varma MV; Steyn SJ; Scott DO; Maurer TS; Bergman A
Pharm Res; 2016 Dec; 33(12):3021-3030. PubMed ID: 27620173
[TBL] [Abstract][Full Text] [Related]
20. Use of HμREL Human Coculture System for Prediction of Intrinsic Clearance and Metabolite Formation for Slowly Metabolized Compounds.
Hultman Ia; Vedin C; Abrahamsson A; Winiwarter S; Darnell M
Mol Pharm; 2016 Aug; 13(8):2796-807. PubMed ID: 27377099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
